Challenges of UDCA Monotherapy for CHILI: High Recurrence Rate of Bile Duct Injury With Potential Immune Interference.
- Published in:
- Liver International, 2025, v. 45, n. 6, p. 1, doi. 10.1111/liv.70157
- By:
- Publication type:
- Article
Works matching DE "URSODEOXYCHOLIC acid"
Results: 889
1
2
Primary biliary cholangitis: a summary of pathogenesis and therapies.
- Published in:
- Annals of Gastroenterology, 2025, v. 38, n. 2, p. 121, doi. 10.20524/aog.2025.0953
- By:
- Publication type:
- Article
3
Study on Liver Neoplasia in Shih Tzu Dog: A Case Report.
- Published in:
- Jurnal Veteriner, 2025, v. 26, n. 1, p. 23, doi. 10.19087/jveteriner.2025.25.1.023
- By:
- Publication type:
- Article
4
Efficacy and Safety of Novel Oral Anti-Cholestatic Agents for Primary Biliary Cholangitis: Meta-Analyses and Systematic Review.
- Published in:
- Pharmaceuticals (14248247), 2025, v. 18, n. 5, p. 697, doi. 10.3390/ph18050697
- By:
- Publication type:
- Article
5
Protective effect of ursodeoxycholic acid and resveratrol against tacrolimus induced hepatotoxicity.
- Published in:
- Biotechnic & Histochemistry, 2023, v. 98, n. 7, p. 471, doi. 10.1080/10520295.2023.2228697
- By:
- Publication type:
- Article
6
Identification, cloning, heterologous expression, and characterization of a NADPH-dependent 7β-hydroxysteroid dehydrogenase from Collinsella aerofaciens.
- Published in:
- Applied Microbiology & Biotechnology, 2011, v. 90, n. 1, p. 127, doi. 10.1007/s00253-010-3052-y
- By:
- Publication type:
- Article
7
Worse Response to Ursodeoxycholic Acid in Primary Biliary Cholangitis Patients with Autoimmune Hepatitis Features.
- Published in:
- Digestive Diseases, 2021, v. 39, n. 4, p. 366, doi. 10.1159/000513331
- By:
- Publication type:
- Article
8
Immunosuppressive Agents for the Treatment of Primary Sclerosing Cholangitis: A Systematic Review and Meta-Analysis.
- Published in:
- Digestive Diseases, 2017, v. 35, n. 5, p. 478, doi. 10.1159/000471874
- By:
- Publication type:
- Article
9
What Comes after Ursodeoxycholic Acid in Primary Biliary Cholangitis?
- Published in:
- Digestive Diseases, 2017, v. 35, n. 4, p. 359, doi. 10.1159/000467547
- By:
- Publication type:
- Article
10
胆汁酸生物学功能及其在水产养殖中的应用前景.
- Published in:
- Feed Research, 2023, v. 46, n. 4, p. 152, doi. 10.13557/j.cnki.issn1002-2813.2023.04.032
- By:
- Publication type:
- Article
11
Usefulness of Ursodeoxycholic Acid in Management of Gallstone Disease in Children.
- Published in:
- Central European Journal of Paediatrics, 2022, v. 18, n. 1, p. 11, doi. 10.5457/p2005-114.310
- By:
- Publication type:
- Article
12
Comparison of composite adverse perinatal outcomes in early- and late-onset intrahepatic cholestasis of pregnancy.
- Published in:
- Jinekoloji-Obstetrik & Neonatoloji Tip Dergisi, 2024, v. 21, n. 3, p. 145
- By:
- Publication type:
- Article
13
Assessing the Relationship Between Intrahepatic Cholestasis of Pregnancy and Exogenous Progesterone Intake.
- Published in:
- Jinekoloji-Obstetrik & Neonatoloji Tip Dergisi, 2024, v. 21, n. 2, p. 57, doi. 10.38136/jgon.1410939
- By:
- Publication type:
- Article
14
Gebeliğin intrahepatik kolestazında hastalığın şiddeti ve tedaviye yanıtın perinatal sonuçlara etkisi.
- Published in:
- Jinekoloji-Obstetrik & Neonatoloji Tip Dergisi, 2023, v. 20, n. 3, p. 1797, doi. 10.38136/jgon.1140832
- By:
- Publication type:
- Article
15
Can simple Non-Invasive Fibrosis Models Determine Prognostic Indicators (Fibrosis and Treatment Response) of Primary Biliary Cholangitis?
- Published in:
- Medical Bulletin of Sisli Etfal Hospital, 2021, v. 55, n. 3, p. 412, doi. 10.14744/SEMB.2021.95825
- By:
- Publication type:
- Article
16
Rapid Determination of Five Residual Solvents in Ursodeoxycholic Acid Raw Materials.
- Published in:
- Separations (2297-8739), 2023, v. 10, n. 11, p. 573, doi. 10.3390/separations10110573
- By:
- Publication type:
- Article
17
293. IN VITRO METABOLISM OF NCX 1000, A NO-DERIVATIVE OF URSODEOXYCHOLIC ACID BY RAT, DOG, AND HUMAN LIVER S9 FRACTION.
- Published in:
- 2003
- Publication type:
- Abstract
18
Intrahepatic cholestasis of pregnancy.
- Published in:
- 2016
- By:
- Publication type:
- Editorial
19
Progressive familial intrahepatic cholestasis type‐3 and multiple sclerosis: lessons from comorbidity.
- Published in:
- Annals of Clinical & Translational Neurology, 2019, v. 6, n. 11, p. 2347, doi. 10.1002/acn3.50883
- By:
- Publication type:
- Article
20
Specific Dermatoses of Pregnancy: A Review.
- Published in:
- West African Journal of Medicine, 2011, v. 30, n. 4, p. 239
- By:
- Publication type:
- Article
21
Co-administration of ursodeoxycholic acid with rosuvastatin/ezetimibe in a non-alcoholic fatty liver disease model.
- Published in:
- Gastroenterology Report, 2022, v. 10, p. 1, doi. 10.1093/gastro/goac037
- By:
- Publication type:
- Article
22
Ursodeoxycholic acid inhibits epithelial-mesenchymal transition, suppressing invasiveness of bile duct cancer cells: An in vitro study.
- Published in:
- Oncology Letters, 2022, v. 24, n. 6, p. N.PAG, doi. 10.3892/ol.2022.13568
- By:
- Publication type:
- Article
23
Ursodeoxycholic acid attenuates 5-fluorouracil-induced mucositis in a rat model.
- Published in:
- Oncology Letters, 2018, v. 16, n. 2, p. 2585, doi. 10.3892/ol.2018.8893
- By:
- Publication type:
- Article
24
ALSUntangled No. 25: Ursodiol.
- Published in:
- Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration, 2014, v. 15, n. 5/6, p. 475, doi. 10.3109/21678421.2014.931010
- Publication type:
- Article
25
Diagnostic Potential of Alternations of Bile Acid Profiles in the Plasma of Patients with Huntington's Disease.
- Published in:
- Metabolites (2218-1989), 2024, v. 14, n. 7, p. 394, doi. 10.3390/metabo14070394
- By:
- Publication type:
- Article
26
Hypoglycemic Activity of Rice Resistant-Starch Metabolites: A Mechanistic Network Pharmacology and In Vitro Approach.
- Published in:
- Metabolites (2218-1989), 2024, v. 14, n. 4, p. 224, doi. 10.3390/metabo14040224
- By:
- Publication type:
- Article
27
Quantitative Assessment of Occipital Metabolic and Energetic Changes in Parkinson's Patients, Using In Vivo 31 P MRS-Based Metabolic Imaging at 7T.
- Published in:
- Metabolites (2218-1989), 2021, v. 11, n. 3, p. 145, doi. 10.3390/metabo11030145
- By:
- Publication type:
- Article
28
Metabolomic Profiling of Bile Acids in an Experimental Model of Prodromal Parkinson's Disease.
- Published in:
- Metabolites (2218-1989), 2018, v. 8, n. 4, p. 71, doi. 10.3390/metabo8040071
- By:
- Publication type:
- Article
29
Ursodeoxycholic Acid Protects Against Arsenic Induced Hepatotoxicity by the Nrf2 Signaling Pathway.
- Published in:
- Frontiers in Pharmacology, 2020, v. 11, p. N.PAG, doi. 10.3389/fphar.2020.594496
- By:
- Publication type:
- Article
30
Genome Analysis Reveals a Synergistic Mechanism of Ursodeoxycholic Acid and Jasminoidin in Mice Brain Repair After Ischemia/Reperfusion: Crosstalk Among Muti-Pathways.
- Published in:
- Frontiers in Pharmacology, 2019, v. 10, p. 1, doi. 10.3389/fphar.2019.01383
- By:
- Publication type:
- Article
31
Ursodeoxycholic acid does not reduce SARS-CoV-2 infection in newly allogeneic hematopoietic stem cell transplantation recipients: a prospective NICHE cohort.
- Published in:
- Frontiers in Cellular & Infection Microbiology, 2024, p. 1, doi. 10.3389/fcimb.2024.1324019
- By:
- Publication type:
- Article
32
Geoepidemiology and changing mortality in primary biliary cholangitis.
- Published in:
- Journal of Gastroenterology, 2017, v. 52, n. 6, p. 655, doi. 10.1007/s00535-017-1333-2
- By:
- Publication type:
- Article
33
Beneficial effects of combined ursodeoxycholic acid and angiotensin-II type 1 receptor blocker on hepatic fibrogenesis in a rat model of nonalcoholic steatohepatitis.
- Published in:
- 2016
- By:
- Publication type:
- journal article
34
Biochemical responses to bezafibrate improve long-term outcome in asymptomatic patients with primary biliary cirrhosis refractory to UDCA.
- Published in:
- Journal of Gastroenterology, 2015, v. 50, n. 6, p. 675, doi. 10.1007/s00535-014-0998-z
- By:
- Publication type:
- Article
35
Biochemical response to ursodeoxycholic acid predicts survival in a North American cohort of primary biliary cirrhosis patients.
- Published in:
- Journal of Gastroenterology, 2014, v. 49, n. 10, p. 1414, doi. 10.1007/s00535-013-0903-1
- By:
- Publication type:
- Article
36
Ursodeoxycholic acid stabilizes the bile salt export pump in the apical membrane in MDCK II cells.
- Published in:
- Journal of Gastroenterology, 2014, v. 49, n. 5, p. 890, doi. 10.1007/s00535-013-0833-y
- By:
- Publication type:
- Article
37
Clinical significance of alanine aminotransferase levels and the effect of ursodeoxycholic acid in hemodialysis patients with chronic hepatitis C.
- Published in:
- Journal of Gastroenterology, 2010, v. 45, n. 3, p. 326, doi. 10.1007/s00535-009-0149-0
- By:
- Publication type:
- Article
38
Hepatic expression of endocannabinoid receptors and their novel polymorphisms in primary biliary cirrhosis.
- Published in:
- Journal of Gastroenterology, 2010, v. 45, n. 1, p. 68, doi. 10.1007/s00535-009-0122-y
- By:
- Publication type:
- Article
39
Early biochemical response to ursodeoxycholic acid predicts symptom development in patients with asymptomatic primary biliary cirrhosis.
- Published in:
- Journal of Gastroenterology, 2009, v. 44, n. 6, p. 630, doi. 10.1007/s00535-009-0051-9
- By:
- Publication type:
- Article
40
Prevention of gallstones by ursodeoxycholic acid after cardiac surgery.
- Published in:
- Journal of Gastroenterology, 2003, v. 38, n. 11, p. 1071, doi. 10.1007/s00535-003-1198-4
- By:
- Publication type:
- Article
41
Prevention of black pigment gallstone formation after cardiac surgery by ursodeoxycholic acid.
- Published in:
- Journal of Gastroenterology, 2003, v. 38, n. 11, p. 1113, doi. 10.1007/s00535-003-1212-x
- By:
- Publication type:
- Article
42
New weapon for primary biliary cirrhosis from Japan.
- Published in:
- 2003
- By:
- Publication type:
- Editorial
43
Efficacy of bezafibrate for chronic GVHD of the liver after allogeneic hematopoietic stem cell transplantation.
- Published in:
- Bone Marrow Transplantation, 2010, v. 45, n. 5, p. 912, doi. 10.1038/bmt.2009.251
- By:
- Publication type:
- Article
44
Facial lesions heralding the onset and relapse of eosinophilic fasciitis.
- Published in:
- Clinical & Experimental Dermatology, 2016, v. 41, n. 4, p. 456, doi. 10.1111/ced.12760
- By:
- Publication type:
- Article
45
Psoriasis treated with ursodeoxycholic acid: three case reports.
- Published in:
- Clinical & Experimental Dermatology, 2007, v. 32, n. 4, p. 398, doi. 10.1111/j.1365-2230.2007.02401.x
- By:
- Publication type:
- Article
46
The Effects of Cold Preservation Solutions Supplemented with UDCA and a-Lipoic Acid on the Viability and Function of Isolated Human Hepatocytes.
- Published in:
- International Journal of Organ Transplantation Medicine, 2019, v. 10, n. 3, p. 108
- By:
- Publication type:
- Article
47
Method development and validation of ursodiol and its major metabolites in human plasma by HPLC-tandem mass spectrometry.
- Published in:
- Clinical Pharmacology, 2019, v. 11, p. 1, doi. 10.2147/CPAA.S187519
- By:
- Publication type:
- Article
48
Hepatoprotective Efficacy of Ursodeoxycholic Acid in Pediatrics Acute Lymphoblastic Leukemia.
- Published in:
- Pediatric Hematology & Oncology, 2012, v. 29, n. 7, p. 627, doi. 10.3109/08880018.2012.713083
- By:
- Publication type:
- Article
49
Bioanalysis of ursodeoxycholic acid and its metabolites and improved oral bioavailability using mixed micelles with poloxamer 407 and polysorbate 80.
- Published in:
- Biotechnology & Bioprocess Engineering, 2024, v. 29, n. 2, p. 313, doi. 10.1007/s12257-024-00064-y
- By:
- Publication type:
- Article
50
Pentaerythritol as an excipient/solid-dispersion carrier for improved solubility and permeability of ursodeoxycholic acid.
- Published in:
- Journal of Excipients & Food Chemicals, 2018, v. 9, n. 3, p. 80
- By:
- Publication type:
- Article